Pritesh S. Karia

4.1k citations

37 papers · 2.5k indexed · 2 hit papers · h-index 21

Co-authors: Chrysalyne D. Schmults Jiali Han Abrar A. Qureshi Joi B. Carter Emily S. Ruiz Anokhi Jambusaria‐Pahlajani Frederick Morgan Gëorge F. Murphy
Topics: Nonmelanoma Skin Cancer Studies (22 papers)Cancer and Skin Lesions (16 papers)Cutaneous lymphoproliferative disorders research (10 papers)
Cited by: Dermatology Epidemiology Oncology
Journals: Journal of Clinical Oncology American Journal of Obstetrics and Gynecology Annals of Oncology
Partner nations: United States United Kingdom Germany

In The Last Decade

Pritesh S. Karia

35 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012

2013 580 citations Pritesh S. Karia, Jiali Han et al. Journal of the American Academy of Dermatology profile →
Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma

2013 388 citations Chrysalyne D. Schmults, Pritesh S. Karia et al. JAMA Dermatology profile →

Peers

Countries citing papers authored by Pritesh S. Karia

Since Specialization

Citations

This map shows the geographic impact of Pritesh S. Karia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pritesh S. Karia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pritesh S. Karia more than expected).

Fields of papers citing papers by Pritesh S. Karia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pritesh S. Karia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pritesh S. Karia. The network helps show where Pritesh S. Karia may publish in the future.

Co-authorship network of co-authors of Pritesh S. Karia

This figure shows the co-authorship network connecting the top 25 collaborators of Pritesh S. Karia. A scholar is included among the top collaborators of Pritesh S. Karia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pritesh S. Karia. Pritesh S. Karia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1344P A real-world (rw) observational study of long-term survival (LTS) and treatment patterns after first-line (1L) osimertinib in patients (pts) with epidermal growth factor receptor (EGFR) mutation-positive (m) advanced non-small cell lung cancer (NSCLC) 2023 ·Annals of Oncology ·Jorge J. Nieva,Pritesh S. Karia,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Elizabeth Martin,Frank Griesinger	1
2	Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States 2022 ·American Journal of Obstetrics and Gynecology ·Pritesh S. Karia,Yongmei Huang,Parisa Tehranifar,Kala Visvanathan,Jason D. Wright,Jeanine M. Genkinger	10
3	Racial and ethnic differences in type II endometrial cancer mortality outcomes: The contribution of sociodemographic, clinicopathologic, and treatment factors 2022 ·Gynecologic Oncology ·Pritesh S. Karia,Yongmei Huang,Parisa Tehranifar,Jason D. Wright,Jeanine M. Genkinger	20
4	Association of Oophorectomy and Fat and Lean Body Mass: Evidence from a Population-Based Sample of U.S. Women 2021 ·Cancer Epidemiology Biomarkers & Prevention ·Pritesh S. Karia,Corinne E. Joshu,Kala Visvanathan	6
5	Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States 2021 ·Cancer Prevention Research ·Pritesh S. Karia,Corinne E. Joshu,Kala Visvanathan	11
6	Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death 2021 ·Journal of the American Academy of Dermatology ·Frederick Morgan,Emily S. Ruiz,Pritesh S. Karia,Robert J. Besaw,Victor Neel,Chrysalyne D. Schmults	15
7	Efficacy and Cost Analysis for Acitretin for Basal and Squamous Cell Carcinoma Prophylaxis in Renal Transplant Recipients 2020 ·Dermatologic Surgery ·(unknown),Chrysalyne D. Schmults,Pritesh S. Karia,Emily S. Ruiz	9
8	Factors predictive of recurrence, metastasis, and death from primary basal cell carcinoma 2 cm or larger in diameter 2019 ·Journal of the American Academy of Dermatology ·Frederick Morgan,Emily S. Ruiz,Pritesh S. Karia,Robert J. Besaw,Victor Neel,Chrysalyne D. Schmults	40
9	Detection of subclinical disease with baseline and surveillance imaging in high-risk cutaneous squamous cell carcinomas 2019 ·Journal of the American Academy of Dermatology ·Jacqueline Maher,Chrysalyne D. Schmults,Fadi Murad,Pritesh S. Karia,Carol B. Benson,Emily S. Ruiz	22
10	A comparison of skin cancer screening and treatment costs at a Massachusetts cancer center, 2008 versus 2013 2018 ·Journal of the American Academy of Dermatology ·Frederick Morgan,(unknown),(unknown),Pritesh S. Karia,Jennifer Y. Lin,Patrick A. Ott,Emily S. Ruiz,David Wang,(unknown),Chrysalyne D. Schmults	3
11	Treatment Patterns, Outcomes, and Patient Satisfaction of Primary Epidermally Limited Nonmelanoma Skin Cancer 2017 ·Dermatologic Surgery ·(unknown),Pritesh S. Karia,Ariana N. Mora,Christine A. Liang,Chrysalyne D. Schmults	26
12	The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management 2016 ·Journal of the American Academy of Dermatology ·Emily S. Ruiz,Pritesh S. Karia,Frederick Morgan,Chrysalyne D. Schmults	58
13	A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance 2015 ·Journal of the American Academy of Dermatology ·Ariana N. Mora,Pritesh S. Karia,(unknown)	50
14	A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change 2014 ·Journal of the American Academy of Dermatology ·Christine A. Liang,Anokhi Jambusaria‐Pahlajani,Pritesh S. Karia,Rosalie Elenitsas,(unknown),Chrysalyne D. Schmults	85
15	Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital Tumor Staging for Cutaneous Squamous Cell Carcinoma 2013 ·Journal of Clinical Oncology ·Pritesh S. Karia,Anokhi Jambusaria‐Pahlajani,David P. Harrington,Gëorge F. Murphy,Abrar A. Qureshi,Chrysalyne D. Schmults	246
16	Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012breakdown → 2013 ·Journal of the American Academy of Dermatology ·Pritesh S. Karia,Jiali Han,Chrysalyne D. Schmults	580
17	The Z-Advancement Flap for Reconstruction of Lateral Nasal Tip and Medial Alar Defects 2013 ·Dermatologic Surgery ·Kyle R. Eberlin,(unknown),Pritesh S. Karia,Joi B. Carter,Christine A. Liang,Chrysalyne D. Schmults	4
18	Evaluation of AJCC Tumor Staging for Cutaneous Squamous Cell Carcinoma and a Proposed Alternative Tumor Staging System 2013 ·JAMA Dermatology ·Anokhi Jambusaria‐Pahlajani,Peter A. Kanetsky,Pritesh S. Karia,Wei‐Ting Hwang,Joel M. Gelfand,(unknown),Rosalie Elenitsas,Xiaowei Xu,Chrysalyne D. Schmults	241
19	Intimate Strangers? Social Networks in HIV-Prevention Groups for Drug Users 2013 ·Journal of Groups in Addiction & Recovery ·Thomas Lyons,Krystal Madkins,Pritesh S. Karia,(unknown)	4
20	The Sun Exposure and Behaviour Inventory (SEBI): validation of an instrument to assess sun exposure and sun protective practices 2012 ·Journal of the European Academy of Dermatology and Venereology ·L. Jennings,Pritesh S. Karia,Anokhi Jambusaria‐Pahlajani,(unknown),Chrysalyne D. Schmults	25

About Pritesh S. Karia

Pritesh S. Karia is a scholar working on Dermatology, Epidemiology and Reproductive Medicine, having authored 37 papers that have together received 2.5k indexed citations. Recurring topics across this work include Nonmelanoma Skin Cancer Studies (22 papers), Cancer and Skin Lesions (16 papers) and Cutaneous lymphoproliferative disorders research (10 papers). The work is most often cited by research in Dermatology (1.6k citations), Epidemiology (2.1k citations) and Oncology (1.4k citations). Pritesh S. Karia has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Chrysalyne D. Schmults, Jiali Han, Abrar A. Qureshi, Joi B. Carter, Emily S. Ruiz, Anokhi Jambusaria‐Pahlajani, Jiali Han, Frederick Morgan, Gëorge F. Murphy and Robert J. Besaw. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact